The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Seismic Disruptions Could Cost Copper and Rhenium Industries...

July 20, 2024

Metro Mining

October 8, 2025

Freegold Intersects 4.25 g/t Au over 67.1m and...

December 5, 2023

Gold, Silver See Gains as Fed Continues to...

May 2, 2024

Completion of First Triage Test Clinical Validation Study

November 9, 2023

Cizzle Brands Corporation Becomes Title Sponsor of the...

February 7, 2025

RAD Granted US FDA Fast Track for RAD101...

June 11, 2025

First Nation Sues McEwen Mining Over Alleged Breach...

February 26, 2025

Crypto Market Recap: CFTC to Hold Crypto Industry...

February 10, 2025

WCNOE Underwriting Completed – A$4.33M Raised

March 17, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,578)
    • Investing (4,641)
    • Politics (6,095)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved